Clin2
NCT05667610Possibly a fitRecruiting

Immune and gut diet study for peanut-allergic children

Peanut AllergyNut Allergy

Treatments studied

Part of Immune system & allergy clinical trials.

This trial studies whether an immune-supportive diet can improve gut health (gut permeability) in children with confirmed peanut or tree-nut allergy. If you join, the researchers will use allergy testing and gut-related diet approaches to see whether symptoms and gut measures change.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
132 people
Ages
3 years to 17 years
Study type
Interventional

Who can take part

  • Your child is 3 to 17 years old
  • Your child has a confirmed peanut or nut allergy within the last 12 months (by a supervised challenge) or had an objective IgE allergy reaction within 1 hour
  • Your child is potty trained and can use the bathroom independently
  • Allergy proof is recent: blood IgE to peanut is high enough or the skin prick test is positive within the last 12 months
  • Your child should not have gut diseases like Crohn’s, celiac disease, or ulcerative colitis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04163562Recruiting· Phase 1/Phase 2
Oral peanut treatment trial for people with peanut allergy

This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.

Pamplona, Navarre
NCT05695261Recruiting· Phase 2
Oral microbiome capsules for peanut allergy in teens

This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.

Boston, Massachusetts
NCT07117669Recruiting· Phase 1/Phase 2
Testing a new peanut allergy treatment (ENP-501)

This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.

Aurora, Colorado
NCT06256146Recruiting
Treating food allergies with modified oral immunotherapy

This study tests a new approach to oral immunotherapy for food allergies, aiming to make it safer and more effective. It's for people who have had a clear allergic reaction to a food and have a positive allergy test.

Montreal, Quebec
NCT06634992Recruiting
Study of food allergy in children under 16

This study is observing children with food allergies who are willing to do an oral food challenge (eating the allergen in a safe clinic setting). It helps doctors learn more about how allergies affect children.

Lille
NCT05738798Enrolling by invitation
Oral allergy treatment for young kids with food allergies

This trial studies an oral immunotherapy approach, where children take tiny, controlled amounts of certain allergy-causing foods to build tolerance. It may help reduce allergic reactions, but only if kids meet safety and monitoring requirements.

Deventer, Overijssel

Hear when a new Peanut Allergy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.